Contraceptives are drugs and devices that are used to prevent pregnancy and sexually transmitted infections. Growing awareness about contraceptives and their offered advantage in preventing pregnancy and sexually transmitted infections (STIs) is the major factor that is driving the contraceptives market. Market players such as Bayer Healthcare in coalition with several NGOs organizes World Contraception Day on September 26th every year, to spread awareness about contraceptives and their benefits. Such awareness drives help the public in making right decisions about their sexual and reproductive health.
Based on the types of products, the global contraceptives market has been categorized into contraceptive drugs and devices. Contraceptive drugs are further classified as contraceptive pills, topical contraceptives and contraceptive injectables. Contraceptive pills dominated the overall drugs segment owing to their high usage in North America and high efficiency in preventing pregnancy and convenience of use. Based on the type of devices, the contraceptives market is further categorized into male and female contraceptive devices.
Female contraceptive devices dominated this segment due to their low cost, ease of usage and high potential in the prevention of pregnancy along with sexually transmitted infections. Female devices market is further differentiated into seven segments: female condoms, intrauterine devices, contraceptive sponges, contraceptive diaphragms, contraceptive patches, subdermal contraceptive implants and non-surgical permanent contraceptive devices. The intrauterine devices (IUD) sub-segment held the largest share of the female contraceptive devices segment in 2013 due to high usage rates in Europe and China. However, the introduction of other effective female contraception devices such as sub-dermal contraceptive implants such as Sino-implant (II), female condom FC2 and non-surgical permanent contraception devices such as Essure, which suits the buying preferences of contraceptive users in Asia, coupled with the rising acceptance of vaginal rings, would reduce the market share of intrauterine devices during the forecast period.
Geographically, the global contraceptives market has been differentiated into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America dominated the global contraceptives market in 2013 due to high incidence rate of unintended pregnancies, availability of favorable reimbursement policies after implementation of the Affordable Care Act and increased use of emergency contraceptive pills and oral contraceptive pills. On the other hand, Asia Pacific is estimated as the most opportunistic market during the forecast period due to strong economic growth in countries such as India, China, Singapore, Philippines, Australia and others. This in turn, has led to increased awareness about the use of contraception for pregnancy prevention and STIs, rising disposable income and demand for healthy life, which is increasing the adoption rate of contraceptives in Asia Pacific.
The global contraceptives market is characterized by the presence of major companies such as Actavis, Inc., Bayers AG, Church & Dwight, Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd. and The Female Health Company. These market players are engaged in growth strategies such as acquisitions, marketing of products (providing free samples or contraceptives in reduced prices) and creating various awareness programs to increase market share and sustain in the highly competitive contraceptives market.